# Personalized Autologous Transplant for Multiple Myeloma

> **NCT04483206** · PHASE1 · RECRUITING · sponsor: **Emory University** · enrollment: 90 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Autologous Hematopoietic Stem Cell Transplantation
- **DRUG:** Melphalan
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04483206
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-20
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04483206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04483206, "Personalized Autologous Transplant for Multiple Myeloma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04483206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*